Efficacy of a single dose of urapidil to prevent arterial hypertension during the period preceding bypass for coronary surgery;Eficacia de una dosis única de urapidilo para la prevención de la hipertensión arterial durante el período pre-bypass de la cirugía coronaria

Revista Espanola de Anestesiologia y Reanimacion

Volumn 47, Issue 8, 2000, Pages 337-342

  Olmos, M ^a,b   Vidarte, M A ^a,b   Ballester, J A ^a,b   Lasuen, J ^a,b   Escobar, A ^a,c  

^a HOSPITAL DE BASURTO   (Spain)

^b Serv Anestesiologia y Reanimacion   (Spain)

^c Unidad de Investigacion   (Spain)

Author keywords

Arterial hypertension; Coronary heart surgery; Nitroprusside; Urapidil

Indexed keywords

NITROPRUSSIDE SODIUM; URAPIDIL;

ANESTHESIA COMPLICATION; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; BRADYCARDIA; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; DRUG EFFICACY; HEART MUSCLE ISCHEMIA; HUMAN; HYPERTENSION; HYPOTENSION; TACHYCARDIA;

ADULT; AGED; ANTIHYPERTENSIVE AGENTS; CORONARY ARTERY BYPASS; EXTRACORPOREAL CIRCULATION; FEMALE; HEMODYNAMIC PROCESSES; HUMANS; HYPERTENSION; INTRAOPERATIVE COMPLICATIONS; MALE; MIDDLE AGED; NITROPRUSSIDE; PIPERAZINES; PREMEDICATION; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 14344279862     PISSN: 00349356     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Jain U, Body SC, Bellows W, Wolman R, Mora Mangano C et al. Multicenter study of target-controlled infusion of propofol-sufentanyl or Mifentanyl-midazolam for coronary artery bypass graft surgery. Anesthesiology 1996; 85: 522-535.
2. Jalonen J, Hynynen M, Kuitunen A, Heikkilä H. Perttilä J, Salmenperä M et al. Dexmedetomidine as an anesthetic adjunct in coronary artery bypass graffting. Anesthesiology 1997; 86: 331-345.
3. Van Wezel HB, Koolen JJ, Visser CA, Dijkhuis JP, Vergroesen I, Moulinj AC et al. Antihypertensive and anti-ischemic effects of nicardipine and nitroprusside in patients undergoing coronary artery bypass grafting. Am J Card ol 1989; 64: 22H-27H.
4. Tobias MA. Comparison of nitroprussice and nitroglycerine for controlling hypertension during coronary artery surgery. Br J Anaesth 1981; 53: 891-897.
5. Van Zwieten PA. Pharmacologic profi e of urapidil. Am J Cardiol 1989; 64: 1D-6D.
6. Santiveri X, Ledesma M. Urapidilo en anestesiología: farmacología e indicaciones. Rev Exp Anestesiol Reanim 1998; 45: 189-197.
7. Prichard B, Tomlinson B, Renondin JC. Urapidil, a multiple-action alfa-blocking drug. Am J Cardiol 1989; 64: 11D-15D.
8. Lepage JY, Pinaud M, Hélias JM, Malinovsky JM, Cozian A, Petite A et al. Accue effects of urapidil on left ventricular function in hypertensive patients: comprison with clonidine using radionuclide angyography. Br J Anaesth 1994; 72: 638-642.
9. Van der Stroom JG, Van Wezel HB, Vergroesen Y, Kal JE, Koolen JJ, Dijkhuis JP et al. Comparison of the effects of urapidil and sodium nitroprusside on haen odynamic state, myocardial metabolism and function in patients during coronary artery surgery. Br J Anaesth 1996; 76: 645-651.
10. Bielen W, Fagard R Staessen J, Lijnen P, Van Hoof R, Amery A. Urapidil-induced hemodynamic changes in humans. Am J Cardiol 1989, 64: 16D-21D.
11. Wang RYC, Chow JSF, Chan KH, Pan HYM, Wong RPY. Acute haemodynamic and myocardial metabolic effects of intravenous urapidil in severe heart failure. Eur Heart J 1984; 5: 745-751.
12. Barankay A, Göb E, Richter JA. Treatment of hypertension in coronary bypass-surgery. Clinical experience with urapidil. Arzneim-Forsch Drug Res 1981; 31: 849-852.
13. Hess W, Schulte U, Tarnow J, Veit S. Comparison of phentolamine and urapidil in controlling acute ultra-operative hypertension in patients subjected to coronary artery bypass surgery. Eur J Anaesth 1985; 2: 21-27.
14. Petry A, Wulf H, Baumgartel M. The influence of ketanserin or urapidil on haemodynamics, stress response and kidney function during operations for myocardial revascularisation. Anaesthesia 1995; 50: 312-316.
15. Langtry HD, Mammen J, Sorkin EM. Urapidil. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potencial in the treatment of hypertension. Drugs 1989; 38: 900-940.
16. Van der Stroom JG Van Wezel HB, Langemeijer JM; Korsten HHM, Kooyman J, Van der Starre PJA et al. A randomized multicenter double-blind comparison of urapidil and ketanserin in hypertensive patients after coronary artery surgery. J Cardiothorac Vasc Anesth 1997; 11: 719-736.
17. London MJ, Hollemberg M, Wong MG, Levenson L, Tubau JF, Browner W et al. Intraoperative myocardial ischemia: localization by continuous 12-lead electrocardiography. Anesthesiology 1988; 69: 232-241.
18. Diessen JJ, Giart M. Comparison of isoflurane and midazolam as hypnotic supplementation to moderately high-dose fentanyl during coronary artery bypass grafting: effects on systemic hemodynamics and early postoperative ecovery profile. J Cardiothorac Vasc Anesth 1997; 11: 740-745.
19. 2-adrenoreceptor agonist mivazerol on hemodynamic stability and myocardial ischemia. Anesthesiology 1997; 86: 346-363.
20. Wallace A, Layug B, Tateo L, Li J, Hollenberg M, Browner W et al. Prophylactic atenolol reduces postoperative myocardial ischemia. Anesthesiology 1998; 88: 7-17.
21. Kirsten R, Nelson K, Neff J, Haerlin R, Steinijans V, Radtke HW. Pharmacodynamics and pharmacokinetics of three different doses of urapidil infused in hypertensive patients. Eur J Clin Pharmacol 1986; 30: 549-552.
22. Bottorff MB, Hood TJ, Rodman JH, Gerlach PA, Ramanathan KB. Pharmacokinetics and pharmacodynamics of urapidil in severe hypertension. J Clin Pharmacol 1988; 28: 420-426.
23. Van der Stroom JG, Van Wezel HB, Piek JJ, Kal JE, Van der Linden R, Vergroesen I et al. Intracoronary-administered urapidil does not influence myocardial contractility, metabolic activity, or coronary sinus blood flow in humans. J Cardiothorac Vasc Anesth 1999; 13: 684-689.
24. Drobinski G, Montalescot G, Fossier JM, Grosgogeat Y. Effets de l'urapidil en injection intraveineuse sur la circulation pulmonaire et la function cardiaque dans l'insuffisance ventriculaire gauche. Ann Cardiol Angèiol 1993; 42: 167-172.
25. Michel JP, Hessel L, Zech K, Steinijans VW. Pharmacokinetics and pharmacodynamics of urapidil in the elderly. En: Amery A, editor. Treatment of hypertension with urapidil: preclinical and clinical update. Londres: Royal Society of Medicine Services Limited, 1986; 39-45.
26. Dooley M, Goa KL. Urapidil. A reappraisal of its use in the managment of hypertension. Drugs 1998; 56: 929-955.
27. Gregorini L, Marco J, Palombo C, Kozakova M, Anguissola GB, Cassagneau B et al. Postischemic left ventricular dysfunction is abolished by alpha-adrenergic blocking agents. J Am Coll Cardiol 1998; 31: 992-1001.
28. Gregorini L, Marco J, Kozkov M, Palombo C, Anguissola G, Marco I et al. Alpha-adrenergic blockade improves recovery of myocardial perfusion and function after coronary stenting in patients with acute myocardial infarction. Circulation 1999; 99: 482-490.